{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:41:48Z","timestamp":1787856108253,"version":"build-2784847793"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004260","name":"Renmin University of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21473251"],"award-info":[{"award-number":["21473251"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.biochi.2023.03.012","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T12:54:24Z","timestamp":1679489664000},"page":"131-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Inhibitory effects of sesquiterpene lactones on the aggregation and cytotoxicity of prion neuropeptide"],"prefix":"10.1016","volume":"211","author":[{"given":"Yan","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-4515","authenticated-orcid":false,"given":"Weihong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2023.03.012_bib1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/19336896.2018.1525254","article-title":"A\u00a0simple in\u00a0vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds","volume":"12","author":"Ladner-Keay","year":"2018","journal-title":"Prion"},{"key":"10.1016\/j.biochi.2023.03.012_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.643254","article-title":"Neurodegenerative disease and the NLRP3 inflammasome","volume":"12","author":"Holbrook","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biochi.2023.03.012_bib3","first-page":"9","article-title":"The quest for cellular prion protein functions in the aged and neurodegenerating brain","author":"Gavin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biochi.2023.03.012_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.biochi.2021.09.005","article-title":"Novel quaternary structures of the human prion protein globular domain","volume":"191","author":"Bortot","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/j.biochi.2023.03.012_bib5","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.bbamem.2018.03.009","article-title":"Aggregation of PrP106-126 on surfaces of neutral and negatively charged membranes studied by molecular dynamics simulations","volume":"1860","author":"Ning","year":"2018","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.biochi.2023.03.012_bib6","first-page":"27","article-title":"Amyloid cross-seeding: mechanism, implication, and inhibition","author":"Subedi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biochi.2023.03.012_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bsheal.2020.09.001","article-title":"Therapeutic implications of prion diseases","volume":"3","author":"Chen","year":"2021","journal-title":"Biosafety and Health"},{"key":"10.1016\/j.biochi.2023.03.012_bib8","doi-asserted-by":"crossref","first-page":"17083","DOI":"10.1039\/C5RA25849A","article-title":"Influence of oxodiperoxovanadate complexes on prion neuropeptide fibril formation","volume":"6","author":"Zhang","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.biochi.2023.03.012_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijbiomac.2021.01.045","article-title":"Ellagic acid and pentagalloylglucose are potential inhibitors of prion protein fibrillization","volume":"172","author":"Yan","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biochi.2023.03.012_bib10","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1007\/s12035-018-1370-8","article-title":"Inhibition of autophagy by captopril attenuates prion peptide-mediated neuronal apoptosis via AMPK activation","volume":"56","author":"Moon","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biochi.2023.03.012_bib11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1021\/acs.jproteome.9b00505","article-title":"Quantitative analysis of in\u00a0vivo methionine oxidation of the human proteome","volume":"19","author":"Bettinger","year":"2020","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.biochi.2023.03.012_bib12","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/chem.200601225","article-title":"Structural and dynamic characterization of copper(II) binding of the human prion protein outside the octarepeat region","volume":"13","author":"Berti","year":"2007","journal-title":"Chemistry"},{"key":"10.1016\/j.biochi.2023.03.012_bib13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/nan.12538","article-title":"Review: PrP 106-126 - 25 years after","volume":"45","author":"Forloni","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.biochi.2023.03.012_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2017.02.021","article-title":"Inhibition of amyloid peptide fibril formation by gold-sulfur complexes","volume":"171","author":"Wang","year":"2017","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.biochi.2023.03.012_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10571-016-0407-7","article-title":"Parkin overexpression ameliorates PrP106-126-induced neurotoxicity via enhanced autophagy in N2a cells","volume":"37","author":"Khan","year":"2017","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.biochi.2023.03.012_bib16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/prot.1157","article-title":"Helix-coil transition of PrP106\u2013126: molecular dynamic study","volume":"45","author":"Levy","year":"2001","journal-title":"Protein Struct. Funct. Genet."},{"key":"10.1016\/j.biochi.2023.03.012_bib17","doi-asserted-by":"crossref","first-page":"15457","DOI":"10.1073\/pnas.93.26.15457","article-title":"PRUSINER, Recombinant scrapie-like prion protein of 106 amino acids is soluble","volume":"93","author":"Tamaki","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biochi.2023.03.012_bib18","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1021\/jacs.8b05925","article-title":"Hetero-oligomeric amyloid assembly and mechanism: prion fragment PrP(106-126) catalyzes the islet amyloid polypeptide beta-hairpin","volume":"140","author":"Ilitchev","year":"2018","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.biochi.2023.03.012_bib19","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1021\/acs.jcim.8b00725","article-title":"Carbon nanoparticles inhibit the aggregation of prion protein as revealed by experiments and atomistic simulations","volume":"59","author":"Zhou","year":"2019","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.biochi.2023.03.012_bib20","doi-asserted-by":"crossref","first-page":"16055","DOI":"10.1039\/C5RA21523D","article-title":"Roles of DMSO-type ruthenium complexes in disaggregation of prion neuropeptide PrP106\u2013126","volume":"6","author":"Zhu","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.biochi.2023.03.012_bib21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1039\/C5MT00029G","article-title":"Inhibitory effects of NAMI-A-like ruthenium complexes on prion neuropeptide fibril formation","volume":"7","author":"Wang","year":"2015","journal-title":"Metallomics"},{"key":"10.1016\/j.biochi.2023.03.012_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25204647","article-title":"Natural and synthetic derivatives of hydroxycinnamic acid modulating the pathological transformation of amyloidogenic proteins","volume":"25","author":"Muronetz","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biochi.2023.03.012_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112197","article-title":"Non-polyphenolic natural inhibitors of amyloid aggregation","volume":"192","author":"Ma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biochi.2023.03.012_bib24","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1007\/s00018-018-2872-2","article-title":"Inhibition of protein misfolding and aggregation by natural phenolic compounds","volume":"75","author":"Dhouafli","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biochi.2023.03.012_bib25","doi-asserted-by":"crossref","first-page":"13793","DOI":"10.1002\/chem.201403188","article-title":"Natural compounds against neurodegenerative diseases: molecular characterization of the interaction of catechins from green tea with Abeta1-42, PrP106-126, and ataxin-3 oligomers","volume":"20","author":"Sironi","year":"2014","journal-title":"Chemistry"},{"key":"10.1016\/j.biochi.2023.03.012_bib26","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3892\/ijmm.2014.1936","article-title":"Gingerol prevents prion protein-mediated neuronal toxicity by regulating HIF prolyl hydroxylase 2 and prion protein","volume":"34","author":"Park","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biochi.2023.03.012_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","article-title":"Resveratrol improves health and survival of mice on a high-calorie diet","volume":"444","author":"Baur","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2023.03.012_bib28","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s12031-014-0459-4","article-title":"Scrapie infection in experimental rodents and SMB-S15 cells decreased the brain endogenous levels and activities of Sirt1","volume":"55","author":"Wang","year":"2015","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.biochi.2023.03.012_bib29","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/j.1471-4159.2007.05105.x","article-title":"Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein - a new mechanism for the inhibition of PrP(Sc) accumulation","volume":"104","author":"Hafner-Bratkovic","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.biochi.2023.03.012_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neulet.2005.06.053","article-title":"Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie","volume":"388","author":"Kocisko","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biochi.2023.03.012_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170266","article-title":"Anti-prion screening for acridine, dextran, and tannic acid using real time-quaking induced conversion: a comparison with PrPSc-infected cell screening","volume":"12","author":"Hyeon","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2023.03.012_bib32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.mencom.2017.09.021","article-title":"Cinnamic acid derivatives as the potential modulators of prion aggregation","volume":"27","author":"Tishina","year":"2017","journal-title":"Mendeleev Commun."},{"key":"10.1016\/j.biochi.2023.03.012_bib33","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/acschembio.5b01043","article-title":"Profiling of multiple targets of artemisinin activated by hemin in cancer cell proteome","volume":"11","author":"Zhou","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biochi.2023.03.012_bib34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nature14412","article-title":"A\u00a0molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria","volume":"520","author":"Mbengue","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2023.03.012_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10408441003610571","article-title":"Toxicity of the antimalarial artemisinin and its dervatives","volume":"40","author":"Efferth","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.biochi.2023.03.012_bib36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/17512433.2014.907523","article-title":"Novel anti-malarial combinations and their toxicity","volume":"7","author":"Angus","year":"2014","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.biochi.2023.03.012_bib37","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biochi.2023.03.012_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cell.2016.11.010","article-title":"Artemisinins target GABAA receptor signaling and impair alpha cell identity","volume":"168","author":"Li","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biochi.2023.03.012_bib39","first-page":"79","article-title":"GABAergic system in the endocrine pancreas: a new target for diabetes treatment","volume":"8","author":"Wan","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.biochi.2023.03.012_bib40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jep.2013.11.012","article-title":"Evaluation of antidiabetic and antihyperlipidemic activity of Artemisia indica linn (aeriel parts) in Streptozotocin induced diabetic rats","volume":"151","author":"Ahmad","year":"2014","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.biochi.2023.03.012_bib41","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1021\/acschemneuro.9b00385","article-title":"Regulation of artemisinin and its derivatives on the assembly behavior and cytotoxicity of amyloid polypeptides hIAPP and abeta","volume":"10","author":"Xu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biochi.2023.03.012_bib42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1023\/A:1023244122450","article-title":"Structure, absolute configuration, and conformation of the antimalarial compound, Artemisinin","volume":"28","author":"Lisgarten","year":"1998","journal-title":"J.\u00a0Chem. Crystallogr."},{"key":"10.1016\/j.biochi.2023.03.012_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/1099-0690(20021)2002:1<113::AID-EJOC113>3.0.CO;2-N","article-title":"C-10 ester and ether derivatives of dihydroartemisinin \u2d1a 10-\u03b1 artesunate, preparation of authentic 10-\u03b2 artesunate, and of other ester and ether derivatives bearing potential aromatic intercalating groups at C-10","volume":"2","author":"Haynes","year":"2002","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.biochi.2023.03.012_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41594-020-0403-y","article-title":"Cryo-EM structure of a human prion fibril with a hydrophobic, protease-resistant core","volume":"27","author":"Glynn","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.biochi.2023.03.012_bib45","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1021\/acschemneuro.2c00206","article-title":"Exploration of isoquinoline alkaloids as potential inhibitors against human islet amyloid polypeptide","volume":"13","author":"Wang","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biochi.2023.03.012_bib46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.biochi.2023.03.012_bib47","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/jvi.74.10.4894-4897.2000","article-title":"CAUGHEY, lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation","volume":"74","author":"Katsumi Doh","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2023.03.012_bib48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0006-3495(03)74514-7","article-title":"Theoretical modeling of prion disease incubation","volume":"85","author":"Kulkarni","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.biochi.2023.03.012_bib49","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.bpj.2011.08.018","article-title":"Fibril Formation of the rabbit\/human\/bovine prion proteins","volume":"101","author":"Zhou","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.biochi.2023.03.012_bib50","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1039\/C4MT00219A","article-title":"Influence of gold-bipyridyl derivants on aggregation and disaggregation of the prion neuropeptide PrP106-126","volume":"6","author":"Zhao","year":"2014","journal-title":"Metallomics"},{"key":"10.1016\/j.biochi.2023.03.012_bib51","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bpj.2015.01.008","article-title":"Structural studies of truncated forms of the prion protein PrP","volume":"108","author":"Wan","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.biochi.2023.03.012_bib52","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1471-4159.2008.05611.x","article-title":"Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP","volume":"107","author":"Rambold","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.biochi.2023.03.012_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31080-7","article-title":"Application of the fragment molecular orbital method to discover novel natural products for prion disease","volume":"8","author":"Choi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2023.03.012_bib54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.sbi.2020.10.019","article-title":"Amyloid aggregation simulations: challenges, advances and perspectives","volume":"67","author":"Strodel","year":"2021","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.biochi.2023.03.012_bib55","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/08927022.2013.824572","article-title":"Molecular dynamics study on the stability of wild-type and the R220K mutant of human prion protein","volume":"40","author":"Chen","year":"2013","journal-title":"Mol. Simulat."},{"key":"10.1016\/j.biochi.2023.03.012_bib56","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.1039\/D1TB00920F","article-title":"Design of carboxylated single-walled carbon nanotubes as highly efficient inhibitors against Abeta40 fibrillation based on the HyBER mechanism","volume":"9","author":"Zhao","year":"2021","journal-title":"J.\u00a0Mater. Chem. B"},{"key":"10.1016\/j.biochi.2023.03.012_bib57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/prot.340120407","article-title":"Stereochemical quality of protein structure coordinates","volume":"12","author":"MacArthur","year":"1992","journal-title":"Protein Struct. Funct. Genet."},{"key":"10.1016\/j.biochi.2023.03.012_bib58","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1039\/C8CP07501H","article-title":"Influence of fullerenol on hIAPP aggregation: amyloid inhibition and mechanistic aspects","volume":"21","author":"Bai","year":"2019","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.biochi.2023.03.012_bib59","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1021\/acschemneuro.9b00480","article-title":"Inhibitory effect of a flavonoid dihydromyricetin against Abeta40 amyloidogenesis and its associated cytotoxicity","volume":"10","author":"Jia","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biochi.2023.03.012_bib60","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijbiomac.2020.10.202","article-title":"Resistance of nepetin and its analogs on the fibril formation of human islet amyloid polypeptide","volume":"166","author":"Xu","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biochi.2023.03.012_bib61","article-title":"Natural products targeting amyloid beta in alzheimer's disease","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biochi.2023.03.012_bib62","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nn.3120","article-title":"Prion propagation, toxicity and degradation","volume":"15","author":"Aguzzi","year":"2012","journal-title":"Nat. Neurosci."},{"issue":"Suppl","key":"10.1016\/j.biochi.2023.03.012_bib63","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.biochi.2023.03.012_bib64","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1039\/C9TB02669J","article-title":"Transition metal complexes as imaging or therapeutic agents for neurodegenerative diseases","volume":"8","author":"Ma","year":"2020","journal-title":"J.\u00a0Mater. Chem. B"},{"key":"10.1016\/j.biochi.2023.03.012_bib65","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1021\/ic500092t","article-title":"Regulation of aggregation behavior and neurotoxicity of prion neuropeptides by platinum complexes","volume":"53","author":"Wang","year":"2014","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.biochi.2023.03.012_bib66","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","article-title":"Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Ha\u00efk","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biochi.2023.03.012_bib67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp-2016-313541","article-title":"Doxycycline in early CJD: a double-blinded randomised phase II and observational study","volume":"88","author":"Varges","year":"2017","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biochi.2023.03.012_bib68","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11427-010-4043-z","article-title":"Progress in the development of therapeutic antibodies targeting prion proteins and beta-amyloid peptides","volume":"53","author":"He","year":"2010","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.biochi.2023.03.012_bib69","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/pathogens2030506","article-title":"Curcumin reduces amyloid fibrillation of prion protein and decreases reactive oxidative stress","volume":"2","author":"Lin","year":"2013","journal-title":"Pathogens"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908423000743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908423000743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:26:26Z","timestamp":1759541186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908423000743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":69,"alternative-id":["S0300908423000743"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2023.03.012","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effects of sesquiterpene lactones on the aggregation and cytotoxicity of prion neuropeptide","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2023.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}